“Carole Nuechterlein”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  3/12/24  as  ↓Signatory

As:  Registrant

        

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Carole Nuechterlein” has been a Signatory for/with  6  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
3/12/24		CA	Aligos Therapeutics, Inc.	14	S-8	—
11/7/23			Roche Finance Ltd.	15	SC 13G/A	CA	Aligos Therapeutics, Inc.
3/6/23		MA	Entrada Therapeutics, Inc.	6	S-8	—
10/28/21		IL	Nuechterlein Carole	3	3	MA	Entrada Therapeutics, Inc.
9/10/20		MA	C4 Therapeutics, Inc.	2	S-1	—
6/7/17			Roche Holding Ltd.	2	3	MD	Senseonics Holdings, Inc.

“Carole Nuechterlein” has/had a Signatory interest in  10  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
11/7/23		CA	Aligos Therapeutics, Inc.	3	SC 13G/A		Roche Finance Ltd.
2/13/23		MA	Eloxx Pharmaceuticals, Inc.	2	SC 13G/A		Roche Finance Ltd.
2/13/23		CA	Jasper Therapeutics, Inc.	1	SC 13G/A		Roche Finance Ltd.
2/14/22		CA	Vaxcyte, Inc.	2	SC 13G/A		Roche Finance Ltd.
10/28/21		MA	Entrada Therapeutics, Inc.	1	3	IL	Nuechterlein Carole
3/2/21		MD	Senseonics Holdings, Inc.	4	SC 13G/A		Roche Finance Ltd.
2/16/21		CA	Allakos Inc.	2	SC 13G		Roche Finance Ltd.
2/16/21		MA	Pandion Therapeutics, Inc.	1	SC 13G		Roche Finance Ltd.
2/16/21		CA	Tempest Therapeutics, Inc.	1	SC 13G/A		Roche Finance Ltd.
2/10/16		IL	AveXis, Inc.	1	3	IL	Nuechterlein Carole